UDP-glucuronosyltransferase 2B7
Details
- Name
- UDP-glucuronosyltransferase 2B7
- Synonyms
- 2.4.1.17
- 3,4-catechol estrogen-specific UDPGT
- UDP-glucuronosyltransferase 2B9
- UDPGT 2B7
- UDPGT 2B9
- UDPGTh-2
- UGTB2B9
- Gene Name
- UGT2B7
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0012557|UDP-glucuronosyltransferase 2B7 MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSA SILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFG DITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTF EKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVL GRPTTLSETMGKADVWLIRNSWNFQFPHPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSG ENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQN DLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTM SSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAA HDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND
- Number of residues
- 529
- Molecular Weight
- 60694.12
- Theoretical pI
- 8.45
- GO Classification
- Functionsglucuronosyltransferase activityProcessesandrogen metabolic process / cellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / lipid metabolic processComponentsendoplasmic reticulum membrane / extracellular exosome / integral component of membrane / intracellular membrane-bounded organelle / membrane
- General Function
- Glucuronosyltransferase activity
- Specific Function
- UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro).
- Pfam Domain Function
- UDPGT (PF00201)
- Transmembrane Regions
- 493-509
- Cellular Location
- Microsome membrane
- Gene sequence
>lcl|BSEQ0012558|UDP-glucuronosyltransferase 2B7 (UGT2B7) ATGTCTGTGAAATGGACTTCAGTAATTTTGCTAATACAACTGAGCTTTTGCTTTAGCTCT GGGAATTGTGGAAAGGTGCTGGTGTGGGCAGCAGAATACAGCCATTGGATGAATATAAAG ACAATCCTGGATGAGCTTATTCAGAGAGGTCATGAGGTGACTGTACTGGCATCTTCAGCT TCCATTCTTTTTGATCCCAACAACTCATCCGCTCTTAAAATTGAAATTTATCCCACATCT TTAACTAAAACTGAGTTGGAGAATTTCATCATGCAACAGATTAAGAGATGGTCAGACCTT CCAAAAGATACATTTTGGTTATATTTTTCACAAGTACAGGAAATCATGTCAATATTTGGT GACATAACTAGAAAGTTCTGTAAAGATGTAGTTTCAAATAAGAAATTTATGAAAAAAGTA CAAGAGTCAAGATTTGACGTCATTTTTGCAGATGCTATTTTTCCCTGTAGTGAGCTGCTG GCTGAGCTATTTAACATACCCTTTGTGTACAGTCTCAGCTTCTCTCCTGGCTACACTTTT GAAAAGCATAGTGGAGGATTTATTTTCCCTCCTTCCTACGTACCTGTTGTTATGTCAGAA TTAACTGATCAAATGACTTTCATGGAGAGGGTAAAAAATATGATCTATGTGCTTTACTTT GACTTTTGGTTCGAAATATTTGACATGAAGAAGTGGGATCAGTTTTATAGTGAAGTTCTA GGAAGACCCACTACATTATCTGAGACAATGGGGAAAGCTGACGTATGGCTTATTCGAAAC TCCTGGAATTTTCAGTTTCCATATCCACTCTTACCAAATGTTGATTTTGTTGGAGGACTC CACTGCAAACCTGCCAAACCCCTGCCTAAGGAAATGGAAGACTTTGTACAGAGCTCTGGA GAAAATGGTGTTGTGGTGTTTTCTCTGGGGTCAATGGTCAGTAACATGACAGAAGAAAGG GCCAACGTAATTGCATCAGCCCTGGCCCAGATCCCACAAAAGGTTCTGTGGAGATTTGAT GGGAATAAACCAGATACCTTAGGTCTCAATACTCGGCTCTACAAGTGGATACCCCAGAAT GACCTTCTAGGTCATCCAAAGACCAGAGCTTTTATAACTCATGGTGGAGCCAATGGCATC TACGAGGCAATCTACCATGGGATCCCTATGGTGGGGATTCCATTGTTTGCCGATCAACCT GATAACATTGCTCACATGAAGGCCAGGGGAGCAGCTGTTAGAGTGGACTTCAACACAATG TCGAGTACAGACTTGCTGAATGCATTGAAGAGAGTAATTAATGATCCTTCATATAAAGAG AATGTTATGAAATTATCAAGAATTCAACATGATCAACCAGTGAAGCCCCTGGATCGAGCA GTCTTCTGGATTGAATTTGTCATGCGCCACAAAGGAGCTAAACACCTTCGGGTTGCAGCC CACGACCTCACCTGGTTCCAGTACCACTCTTTGGATGTGATTGGGTTCCTGCTGGTCTGT GTGGCAACTGTGATATTTATCGTCACAAAATGTTGTCTGTTTTGTTTCTGGAAGTTTGCT AGAAAAGCAAAGAAGGGAAAAAATGATTAG
- Chromosome Location
- 4
- Locus
- 4q13
- External Identifiers
Resource Link UniProtKB ID P16662 UniProtKB Entry Name UD2B7_HUMAN GenBank Protein ID 340080 GenBank Gene ID J05428 HGNC ID HGNC:12554 - General References
- Ritter JK, Sheen YY, Owens IS: Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates. J Biol Chem. 1990 May 15;265(14):7900-6. [Article]
- Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article]
- Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article]
- Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article]
- Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR: Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol. 2007 Jun 1;369(2):498-511. Epub 2007 Mar 30. [Article]
- Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, Miners JO: Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics. 2000 Nov;10(8):679-85. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00678 Losartan approved unknown substrate Details DB00586 Diclofenac approved, vet_approved unknown substrate Details DB00749 Etodolac approved, investigational, vet_approved unknown substrate Details DB00712 Flurbiprofen approved, investigational unknown substrate Details DB01050 Ibuprofen approved unknown substrate Details DB00788 Naproxen approved, vet_approved unknown substrate Details DB01252 Mitiglinide investigational unknown substrate Details DB06737 Zaltoprofen experimental unknown substrate Details DB01544 Flunitrazepam approved, illicit unknown inhibitor Details DB06403 Ambrisentan approved, investigational unknown substrate Details DB00197 Troglitazone approved, investigational, withdrawn unknown substrate Details DB00295 Morphine approved, investigational no substrate Details DB00328 Indomethacin approved, investigational unknown substrateinhibitor Details DB00688 Mycophenolate mofetil approved, investigational unknown substrate Details DB00973 Ezetimibe approved unknown substrate Details DB01024 Mycophenolic acid approved, investigational unknown substrate Details DB06777 Chenodeoxycholic acid approved unknown inhibitor Details DB06235 Vadimezan investigational unknown substrate Details DB00445 Epirubicin approved unknown substrate Details DB06204 Tapentadol approved unknown substrate Details DB08860 Pitavastatin approved unknown substrate Details DB06695 Dabigatran etexilate approved unknown substrate Details DB06207 Silodosin approved unknown substrate Details DB00495 Zidovudine approved unknown substrate Details DB00227 Lovastatin approved, investigational unknown substrate Details DB00641 Simvastatin approved unknown substrate Details DB00842 Oxazepam approved unknown substrate Details DB00564 Carbamazepine approved, investigational unknown substrate Details DB00318 Codeine approved, illicit unknown substrate Details DB01095 Fluvastatin approved unknown substrate Details DB00313 Valproic acid approved, investigational unknown substrate Details DB06292 Dapagliflozin approved no substrate Details DB13874 Enasidenib approved, investigational unknown substrate Details DB06230 Nalmefene approved, investigational, withdrawn no substrate Details DB13783 Acemetacin approved, investigational no substrate Details DB11827 Ertugliflozin approved, investigational no substrate Details DB11638 Artenimol approved, experimental, investigational no substrate Details DB01026 Ketoconazole approved, investigational unknown inhibitor Details DB05928 Dovitinib investigational unknown inhibitor Details DB09213 Dexibuprofen approved, investigational unknown substrate Details DB01174 Phenobarbital approved, investigational unknown inducer Details DB00465 Ketorolac approved unknown substrate Details DB00327 Hydromorphone approved, illicit no substrate Details DB00598 Labetalol approved unknown substrate Details DB00675 Tamoxifen approved unknown substrate Details DB01136 Carvedilol approved, investigational unknown substrate Details DB01241 Gemfibrozil approved unknown substrate Details DB01217 Anastrozole approved, investigational unknown substrate Details DB09212 Loxoprofen approved unknown substrate Details DB06119 Cenobamate approved, investigational unknown substrate Details DB00983 Formoterol approved, investigational unknown substrate Details DB01006 Letrozole approved, investigational unknown substrate Details DB00977 Ethinylestradiol approved unknown substrate Details DB13609 Umifenovir investigational unknown inhibitor Details DB11837 Osilodrostat approved, investigational unknown substrate Details DB11936 Bempedoic acid approved, investigational unknown substrate Details DB00870 Suprofen approved, withdrawn unknown substrate Details DB09038 Empagliflozin approved unknown substrate Details DB09274 Artesunate approved, investigational unknown substrate Details DB00514 Dextromethorphan approved unknown substrate Details DB00784 Mefenamic acid approved unknown inhibitor Details DB04854 Febuxostat approved no substrate Details DB12016 Ponesimod approved, investigational unknown substrate Details DB08893 Mirabegron approved no substrate Details DB12235 Estetrol approved, investigational unknown substrate Details DB08804 Nandrolone decanoate approved, illicit unknown substrate Details DB12597 Asciminib approved, investigational no substrate Details DB12713 Sotagliflozin approved, investigational no substrate Details DB09061 Cannabidiol approved, investigational no substrateinhibitor Details DB14737 Cannabinol experimental, investigational unknown substrateinducer Details DB14009 Medical Cannabis experimental, investigational unknown substrateinhibitorinducer Details DB12095 Telotristat ethyl approved, investigational no inducer Details DB05239 Cobimetinib approved, investigational no substrate Details DB12243 Edaravone approved, investigational no substrate Details DB00683 Midazolam approved, illicit no substrate Details DB00755 Tretinoin approved, investigational, nutraceutical unknown substrate Details DB06045 Trofinetide approved, investigational unknown inhibitor Details DB12255 Vadadustat approved, investigational unknown substrate Details DB15114 Vamorolone approved, investigational no substrate Details DB12218 Capivasertib approved, investigational no substrate Details DB00555 Lamotrigine approved, investigational unknown substrate Details DB00503 Ritonavir approved, investigational no inducer Details DB14635 Curcumin sulfate experimental unknown inhibitor Details DB00794 Primidone approved, vet_approved unknown inducer Details DB00783 Estradiol approved, investigational, vet_approved unknown substrateinducer Details DB00714 Apomorphine approved, investigational unknown substrate Details DB11796 Fostemsavir approved, investigational unknown substrate Details DB00871 Terbutaline approved unknown substrate Details DB00960 Pindolol approved, investigational unknown substrate Details DB12471 Ibrexafungerp approved, investigational unknown substrate Details